Axa S.A. Deciphera Pharmaceuticals, Inc. Transaction History

Axa S.A.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$40.39 - $56.73 $2.08 Million - $2.92 Million	-51,479 Reduced 88.94%	6,400 $287,000
Q4 2020 Feb 12, 2021	BUY	$51.77 - $66.18 $107,267 - $137,124	2,072 Added 3.71%	57,879 $3.3 Million
Q3 2020 Nov 13, 2020	SELL	$43.8 - $58.16 $319,521 - $424,277	-7,295 Reduced 11.56%	55,807 $2.86 Million
Q2 2020 Aug 14, 2020	SELL	$37.05 - $65.03 $191,511 - $336,140	-5,169 Reduced 7.57%	63,102 $3.77 Million
Q1 2020 May 15, 2020	BUY	$33.63 - $69.4 $2.3 Million - $4.74 Million	68,271 New	68,271 $2.81 Million
Q3 2019 Nov 14, 2019	SELL	$19.95 - $38.85 $2.35 Million - $4.57 Million	-117,586 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$21.05 - $26.21 $174,251 - $216,966	-8,278 Reduced 6.58%	117,586 $2.65 Million
Q3 2018 Nov 08, 2018	BUY	$33.57 - $42.1 $1.47 Million - $1.84 Million	43,668 Added 53.13%	125,864 $4.87 Million
Q2 2018 Aug 13, 2018	BUY	$20.06 - $44.95 $1.65 Million - $3.69 Million	82,196 New	82,196 $3.23 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.